BASF’s Coatings Cash Injection and Buyback Expiry Set the Stage for CoreShift Cost Discipline

BASF receives EU approval for €7.7B coatings sale to Carlyle, unlocking €5.8B cash, while its €1.5B buyback expires. The focus shifts to cost cuts under CoreShift.

BASF is entering a pivotal stretch where two major financial levers are pulling in opposite directions. The EU’s green light for the €7.7 billion sale of its global coatings business to Carlyle will bring in a €5.8 billion pre-tax cash pile, while the €1.5 billion share buyback programme, a steady market prop for months, is set to expire at the end of June. The combination shifts the narrative from financial engineering to operational delivery.

The Coatings Payday

On 2 June, the European Commission gave its formal blessing to the divestiture, subject to one condition: Carlyle must offload the polysulphide business of its subsidiary Nouryon to preserve competition in aerospace sealants. For BASF, the deal unlocks a substantial cash injection. The enterprise value stands at €7.7 billion, with roughly €5.8 billion flowing to the German chemical giant in cash before tax. It will retain a 40% stake in the newly independent entity, keeping a slice of any future upside.

Shortly after the EU nod, BASF also deepened its tie-up with US-based Encina Development Group. The partners are planning a large-scale plant on the US Gulf Coast to produce chemically recycled benzene from plastic waste. BASF’s role is initially advisory, contributing procurement and project planning expertise. A final investment decision is still pending, but the company has secured an option to take a direct equity stake in future projects.

The Buyback Countdown

The coatings cash arrives just as the current buyback programme runs its course. Launched in November 2025, the €1.5 billion initiative is scheduled to conclude by the end of June 2026. As of 1 June, BASF had repurchased 27,835,549 shares, including 950,000 on that day alone. The shares are destined for cancellation, which has been a steady support for earnings per share.

The broader capital return framework, unveiled at the September 2024 Capital Markets Day, targets up to €4 billion in buybacks through 2028. Over the same period, BASF plans total shareholder returns of at least €12 billion, with around €8 billion coming from dividends and the remainder from buybacks. The current programme is merely the first tranche.

With the buyback ending, that technical tailwind disappears. The stock is not under automatic selling pressure, but the operating business will now have to do more of the heavy lifting. The shares last traded at €50.83, up 0.51% on the day and showing a year-to-date gain of roughly 13.6%. They sit below the 50-day moving average of €52.41 but remain 8.55% above the 200-day line, suggesting a neutral near-term tone. The relative strength index stood at 42.6 in the primary article, also indicating a balanced market phase.

CoreShift Takes Centre Stage

As the buyback fades, the spotlight turns to the restructuring programme CoreShift. BASF aims to slash fixed costs in its core divisions — Chemicals, Materials, Industrial Solutions, and Nutrition & Care — by 20% by 2029, using 2024 as the baseline. The urgency is underlined by the situation at Ludwigshafen, the sprawling home site that has now posted four consecutive loss years. Since the start of 2024, BASF has cut roughly 2,800 jobs there.

For 2026, management expects EBITDA before special items in a range of €6.2 billion to €7.0 billion, a target that hinges on demand recovery. In the first quarter, EBITDA came in at €2.4 billion, fractionally below the prior year, though earnings per share improved from €0.91 to €1.06.

The wider industry environment offers little tailwind. Germany’s chemical-pharmaceutical association VCI cites bureaucracy, high energy costs, and global turbulence as persistent drags. It forecasts stagnant production for the sector in 2026, with chemical output alone shrinking 1% and a 3.5% drop in sales on declining prices. BASF’s own first-quarter production fell 2.8% sequentially and was nearly 6% lower year on year, while capacity utilisation remained stuck at 75.1%.

Upcoming Milestones

The calendar is packed with events that will test the company’s strategy. On 8 June, management will present details of the giant new site in Zhanjiang, China. Later this month, the buyback programme expires. Then on 29 July, the second-quarter earnings release will be the first real chance to see whether CoreShift is gaining traction.

That report will arrive after the buyback has ended, removing the financial engineering crutch. Investors will be looking for signs that the €5.8 billion coatings windfall is being deployed wisely — whether into the balance sheet, the dividend, or the planned IPO of the agricultural business targeted for 2027 — while the underlying chemical cycle remains stubbornly weak. For BASF, the narrative has clearly moved from buyback support to operational proof.